Education
About Us
Working with TipRanks
Follow Us
Maravai Lifesciences Holdings, Inc. (MRVI)
:MRVI
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 259.19M | $ 288.94M | $ 883.00M | $ 799.24M | $ 284.10M |
| Gross Profit | $ 108.31M | $ 140.20M | $ 714.04M | $ 658.68M | $ 204.45M |
| Operating Income | $ -235.62M | $ -31.65M | $ 574.22M | $ 554.64M | $ 67.60M |
| EBITDA | $ -156.92M | $ 712.41M | $ 609.99M | $ 585.78M | $ 138.27M |
| Net Income | $ -144.85M | $ -119.03M | $ 490.66M | $ 469.25M | $ 76.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 322.40M | $ 574.96M | $ 632.14M | $ 551.27M | $ 236.18M |
| Total Assets | $ 1.01B | $ 1.49B | $ 2.28B | $ 1.92B | $ 1.27B |
| Total Debt | $ 376.69M | $ 610.97M | $ 585.26M | $ 534.31M | $ 590.78M |
| Net Debt | $ 54.29M | $ 36.01M | $ -46.88M | $ -16.96M | $ 354.60M |
| Total Liabilities | $ 431.04M | $ 697.57M | $ 1.38B | $ 1.37B | $ 1.12B |
| Stockholders' Equity | $ 325.29M | $ 416.75M | $ 545.22M | $ 315.50M | $ 88.51M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.19M | $ 60.67M | $ 518.89M | $ 353.72M | $ 126.78M |
| Operating Cash Flow | $ 7.46M | $ 126.22M | $ 535.98M | $ 368.57M | $ 152.19M |
| Investing Cash Flow | $ -24.32M | $ -122.31M | $ -267.61M | $ 105.66M | $ 6.07M |
| Financing Cash Flow | $ -234.47M | $ -61.09M | $ -187.50M | $ -159.05M | $ 53.21M |